|
MechanismPLA2G10 inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with CS Astra Ltd.
0 Patents (Medical) associated with CS Astra Ltd.
100 Deals associated with CS Astra Ltd.
100 Translational Medicine associated with CS Astra Ltd.